PHK
JUNO

Point72 Hong Kong’s Juno Therapeutics, Inc. JUNO Stock Holding History

Point72 Hong Kong’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,000
Closed -$90K – 1132
2016
Q3 		$90K Buy
3,000
+2,900
+2,900% +$90.2K 0.05% 372
2016
Q2 		$4K Buy
+100
New +$4.15K ﹤0.01% 478
2015
Q3 		– Sell
-2,300
Closed -$123K – 200
2015
Q2 		$123K Buy
+2,300
New +$122K 0.24% 78

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Point72 Hong Kong's JUNO Position: Q4 2016 in Review

Point72 Hong Kong sold out of Juno Therapeutics, Inc. (JUNO) in Q4 2016, closing a stake of 3,000 shares — an estimated $90K sold.

Point72 Hong Kong first reported a position in JUNO in Q2 2015 and held it in 3 quarters. The position peaked at $123K in Q2 2015. 159 funds tracked by Wall St. Rank hold JUNO as of Q4 2016.

  • Point72 Hong Kong reported no remaining Juno Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Point72 Hong Kong sold 3,000 Juno Therapeutics, Inc. shares in Q4 2016, an estimated $90K.
  • Point72 Hong Kong first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
  • Point72 Hong Kong's Juno Therapeutics, Inc. position peaked at $123K in Q2 2015.
  • 159 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2016.

Based on Point72 Hong Kong's 13F filing for Q4 2016, filed 14 Feb 2017.